NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT02388919,Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0303）,https://clinicaltrials.gov/study/NCT02388919,ALTER0303,COMPLETED,"Evaluate the efficacy and safety of Anlotinib as the 3-line treatment of patients with advanced non-small lung cancer, with placebo control.",NO,Non-small Cell Lung Cancer,DRUG: Anlotinib|DRUG: Placebo,"Overall Survival (OS), From randomization until death (up to 24 months)","Progress free survival (PFS), each 42 days up to PD or death(up to 24 months)|Objective Response Rate (ORR), each 42 days up to intolerance the toxicity or PD (up to 24 months)|Disease Control Rate (DCR), each 42 days up to intolerance the toxicity or PD (up to 24 months)|Number of Participants with Adverse Events as a Measure of Safety and Tolerability, Until 30 day safety follow-up visit",,"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,439,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",ALTN-03-IIB,2015-02-26,2017-01-05,2017-01-06,2015-03-17,,2017-09-18,"Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China|Capital Medical University, Beijing Chest Hospital, Beijing, Beijing, China|Chinese Academy of Medical Sciences Cancer Hospital, Beijing, Beijing, China|Peking Union Medical College Hospital, Beijing, Beijing, China|Chongqing Cancer Hospital, Chongqing, Chongqing, China|Xinqiao Hospital, Chongqing, Chongqing, China|Fujian Province Tumor Hospital, Fuzhou, Fujian, China|Gansu Province Tumor Hospital, Lanzhou, Gansu, China|Gansu Provincial People 's Hospital, Lanzhou, Gansu, China|Lanzhou Military General Hospital, Lanzhou, Gansu, China|First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China|First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China|Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China|Harbin medical university affiliated tumor hospita, Harbin, Heilongjiang, China|Henan Province Tumor Hospital, Luoyan, Henan, China|Hunan Province Tumor Hospital, Changsha, Hunan, China|Xiangya Hospital Central South University, Changsha, Hunan, China|Lianyungang First People 's Hospital, Lianyungang, Jiangsu, China|Xuzhou Medical College Hospital, Xuzhou, Jiangsu, China|Jiangxi Province Tumor Hospital, Nanchang, Jiangxi, China|Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China|Jilin Province Tumor Hospital, Changchun, Jilin, China|Liaoning Provincial Tumor Hospital, Shenyang, Liaoning, China|Qilu Hospital，Shandong University, Jinan, Shandong, China|Shandong Province Tumor Hospital, Jinan, Shandong, China|Linyi City Tumor Hospita, Linyi, Shandong, China|Chest hospital affiliated to Shanghai jiaotong university, Shanghai, Shanghai, 200000, China|Cancer Hospital of Fudan University, Shanghai, Shanghai, China|Shanghai Changhai Hospital, Shanghai, Shanghai, China|Xinhua hospital affiliated to Shanghai jiaotong university, Shanghai, Shanghai, China|First Affiliated Hospital of Xi'an Jiaotong University, Xian, Shanxi, China|Tang Du Hospital, Xian, Shanxi, China|West China Hospital , Sichuan University, Chengdu, Sichuan, China|Sichuan Cancer Hospital, Chongqing, Sichuan, China|20th Floor, Block C, Lake Road, Hexi District, Tianjin Medical University Cancer Institute and Hospital ., Tianjin, Tianjin, 300600, China|Tianjin Medical University General Hospital, Tianjin, Tianjin, China|Yunnan Province Tumor Hospital, Kunming, Yunnan, China|The First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, China|The Second Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, China|Zhejiang Province Tumor Hospital, Hangzhou, Zhejiang, China",
